Overview

Study to Evaluate the Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir Alone in Hospitalized Adults With Influenza A Infection Requiring Oxygen Support

Status:
Completed

Trial end date:
2018-11-22

Target enrollment:

Participant gender:

Summary

This study is to compare the efficacy and safety of VIS410 in combination with oseltamivir vs oseltamivir alone in severely ill subjects with influenza A infection requiring oxygen support.

Phase:

Phase 2

Details

Lead Sponsor:

Visterra, Inc.

Treatments:

Oseltamivir